Hormone Therapy
Deuterated Oxytocin for Postpartum Hemorrhage
This trial will help researchers understand why oxytocin, the first-line drug to prevent uterine atony, sometimes fails. Participants will receive a single dose of deuterium-labeled oxytocin, followed by an infusion of unlabeled oxytocin. Blood samples will be taken to measure plasma concentrations of both oxytocins over time.